Ron Honig (’93) Named SVP, General Counsel & Company Secretary of EyePoint Pharmaceuticals
WATERTOWN, Mass., Nov. 27, 2018 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced the appointment of Ron Honig, Esq. (’93), as senior vice president, general counsel and company secretary, effective immediately. In this new role, Mr. Honig will the oversee the Company’s legal activities, including the legal aspects of licensing, compliance, strategic transactions, and business development.
Mr. Honig brings to EyePoint more than 25 years of legal experience in the medical device, biotechnology, contract manufacturing and legal services industries. As lead in-house counsel to publicly-traded companies and private equity portfolio companies in the global healthcare industry, Mr. Honig has managed legal and compliance functions and has had responsibility for a wide variety of business transactions.